Retraction Note: miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3

F-J Meng1, F-M Meng, H-X Wu

  • 1Laboratory Medicine, Yidu Central Hospital of Weifang City, Weifang, Shandong, China.

Insights

This study on prostate cancer has been retracted due to data inaccuracies and figure inconsistencies. The article investigated microRNA-564's role in inhibiting cancer metastasis and proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Prostate cancer is a leading cause of cancer-related mortality globally.
  • MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
  • MLLT3 has been implicated in various cancers, including prostate cancer.

Purpose of the Study:

  • To investigate the role of microRNA-564 (miR-564) in prostate cancer.
  • To determine if miR-564 affects metastasis and proliferation of prostate cancer cells.
  • To identify MLLT3 as a potential target of miR-564 in prostate cancer.

Main Methods:

  • The study utilized cell lines and molecular biology techniques.
  • Methods included assessing cell proliferation, migration, and invasion assays.
  • Western blot analysis was performed to evaluate protein expression levels.

Main Results:

  • miR-564 was found to inhibit prostate cancer cell metastasis and proliferation.
  • MLLT3 was identified as a direct target of miR-564.
  • Downregulation of miR-564 was associated with increased MLLT3 expression.

Conclusions:

  • miR-564 acts as a tumor suppressor in prostate cancer.
  • Targeting MLLT3 by miR-564 offers a potential therapeutic strategy.
  • Further research is warranted to explore the clinical applications of miR-564 in prostate cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K